Nursing Care for HCV Patients: Practical Strategies to Optimize Outcomes

In this case-based module, Murielle Francois, IDE; Maria Lopez-Parra, RN, Master in Bioethics, Master in Education and ICT e-learning; and Josephine Schulz, BSc (Hons), RGN MSc, provide strategies for providing optimal patient care as it relates to patient education and pretreatment counseling; adverse event prevention, identification, and management; and on-treatment patient support during HCV therapy.
person default
Murielle Francois, IDE
Maria Lopez-Parra, RN, Master in Bioethics, Master in Education and ICT e-learning
Josephine Schulz, BSc(Hons) RGN MSc
Registered Nurses: 1.0 Nursing contact hour
Released: April 19, 2013 Expiration: April 18, 2014

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Provide pretreatment education to patients who are considering triple therapy for HCV
  • Implement practical strategies to prevent or mitigate common adverse events associated with triple therapy
  • Improve patients’ motivation and ability to adhere to triple therapy regimens
  • Provide appropriate care and counsel for patients and their families

Acknowledgements

Co-provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Educational grant provided by:
Roche

Information on this Educational Activity

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty

Murielle Francois, IDE

Nurse
Department of Hepatology
C.H.U. Henri MONDOR
Creteil, France

Murielle Francois, IDE, has no significant financial relationships to disclose.
Maria Lopez-Parra, RN, Master in Bioethics, Master in Education and ICT e-learning
Registered Nurse
Day-care Hospital of Digestive Diseases
Hospital of Sabadell Corporació Sanitària Parc Taulí, Institut Universitari Parc Taulí – UAB
Sabadell, Barcelona, Spain
Maria Lopez-Parra, RN, Master in Bioethics, Master in Education and ICT e-learning, has no significant financial relationships to disclose.
Josephine Schulz, BSc(Hons) RGN MSc

Lead Clinical Nurse Specialist Viral Hepatitis
Department of Hepatology
Barts Health NHS Trust
London, United Kingdom

Josephine Schulz, BSc (Hons), RGN MSc, has disclosed that she has received consulting fees from Janssen and Roche and that her spouse has received a salary from Roche.

Staff

Jennifer M. Blanchette, PhD

Associate Managing Editor

Jennifer Blanchette, PhD, has no significant financial relationships to disclose.
Edward King, MA

Chief Innovation Officer

Edward King, MA, has no significant financial relationships to disclose.
Jenny Schulz, PhD

Senior Managing Editor

Jenny Schulz, PhD, has no significant financial relationships to disclose.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD; Jan Schultz, RN, MSN, CCMEP; and Patricia Staples, MSN, NP-C, CCRN hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM) and Clinical Care Options, LLC and do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM and Clinical Care Options, LLC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This activity is intended for registered nurses and other healthcare professionals who provide care as part of the treatment team for patients with chronic hepatitis C.

Goal

The goal of this activity is to enhance participants’ confidence and competence in providing high-quality care to patients who are considering or already receiving triple therapy for chronic hepatitis C.

Nursing Continuing Education

Credit Designation

This educational activity for 1.0 contact hour is provided by Postgraduate Institute for Medicine.

Accreditation Statement

Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from April 19, 2013, through April 18, 2014:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Expert commentary from CCO on how providers can act as advocates for increased access to HCV care for persons who use drugs and incarcerated individuals

Oluwaseun Falade-Nwulia, MBBS, MPH Released: December 18, 2019

Watch this CME/MOC-certified video from a live symposium for expert guidance on approaches to improve diagnosis and treatment of HCV, HBV, and NASH.

Paul Y. Kwo, MD
Program Director
Manal F. Abdelmalek, MD, MPH Oluwaseun Falade-Nwulia, MBBS, MPH
Physicians: maximum of 1.5 AMA PRA Category 1 Credits US Physicians: maximum of 1.5 Medical Knowledge MOC point(s) Released: December 17, 2019 Expiration: December 16, 2020

Audio from CCO faculty Dr. Nancy Reau on strategies to address gaps in viral hepatitis care: learn how to prevent HAV and HBV, how to screen for and treat HCV

Nancy Reau, MD Released: December 3, 2019

Downloadable slides on data from AALSD 2019 selected by expert faculty as relevant to care of patients with viral hepatitis or NAFLD/NASH, as reported by Clinical Care Options.

Ira M. Jacobson, MD Nancy Reau, MD Released: December 2, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?